Splenic vein thrombosis screening: Difference between revisions
Jump to navigation
Jump to search
| (3 intermediate revisions by 2 users not shown) | |||
| Line 3: | Line 3: | ||
{{CMG}} ; {{AE}} {{Vbe}} | {{CMG}} ; {{AE}} {{Vbe}} | ||
==Overview== | ==Overview== | ||
There is insufficient [[evidence]] to recommend routine [[Screening (medicine)|screening]] for [[splenic vein thrombosis]]. However, routine screening of [[portal]] and [[splenic vein]] [[thrombosis]] after elective [[splenectomy]] is warranted because it allows | There is insufficient [[evidence]] to recommend routine [[Screening (medicine)|screening]] for [[splenic vein thrombosis]]. However, routine screening of [[portal]] and [[splenic vein]] [[thrombosis]] after elective [[splenectomy]] is warranted because it allows the initiation of [[anticoagulant]] therapy and avoid further life-threatening [[Complications During and Following Cardiac Catheterization and Percutaneous Coronary Intervention|complications]]. The incidence of [[portal]] and [[splenic vein]] [[thrombosis]] is particularly high among patients operated on for [[lymphoma]] or with [[splenomegaly]]. | ||
== Screening== | == Screening== | ||
There is insufficient [[evidence]] to [[Recommended Daily Allowance|recommend]] routine [[Screening (medicine)|screening]] for [[splenic vein thrombosis]]. However, routine [[Screening (medicine)|screening]] of [[portal]] and [[splenic vein thrombosis]] after elective | There is insufficient [[evidence]] to [[Recommended Daily Allowance|recommend]] routine [[Screening (medicine)|screening]] for [[splenic vein thrombosis]]. However, routine [[Screening (medicine)|screening]] of [[portal]] and [[splenic vein thrombosis]] after elective [[Splenectomy|splenectom]]<nowiki/>y is warranted because it allows to start [[anticoagulant]] therapy and avoid further life-threatening [[Complications During and Following Cardiac Catheterization and Percutaneous Coronary Intervention|complications]]. The incidence of [[portal]] and [[splenic vein thrombosis]] is particularly high among [[patients]] operated on for [[lymphoma]] or with [[splenomegaly]].<ref name="pmid27639911">{{cite journal |vauthors=Bouvier A, Gout M, Audia S, Chalumeau C, Rat P, Deballon O |title=[Routine screening of splenic or portal vein thrombosis after splenectomy] |language=French |journal=Rev Med Interne |volume=38 |issue=1 |pages=3–7 |year=2017 |pmid=27639911 |doi=10.1016/j.revmed.2016.08.003 |url=}}</ref><ref name="pmid26080307">{{cite journal| author=Valla D| title=Splanchnic Vein Thrombosis. | journal=Semin Thromb Hemost | year= 2015 | volume= 41 | issue= 5 | pages= 494-502 | pmid=26080307 | doi=10.1055/s-0035-1550439 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26080307 }}</ref><ref name="pmid29211374">{{cite journal| author=Gouin B, Robert-Ebadi H, Casini A, Beauverd Y, Fontana P, Righini M et al.| title=[Splanchnic vein thrombosis]. | journal=Rev Med Suisse | year= 2017 | volume= 13 | issue= 586 | pages= 2138-2143 | pmid=29211374 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29211374 }}</ref> | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Latest revision as of 16:02, 1 March 2018
|
Splenic vein thrombosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Splenic vein thrombosis screening On the Web |
|
American Roentgen Ray Society Images of Splenic vein thrombosis screening |
|
Risk calculators and risk factors for Splenic vein thrombosis screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Vindhya BellamKonda, M.B.B.S [2]
Overview
There is insufficient evidence to recommend routine screening for splenic vein thrombosis. However, routine screening of portal and splenic vein thrombosis after elective splenectomy is warranted because it allows the initiation of anticoagulant therapy and avoid further life-threatening complications. The incidence of portal and splenic vein thrombosis is particularly high among patients operated on for lymphoma or with splenomegaly.
Screening
There is insufficient evidence to recommend routine screening for splenic vein thrombosis. However, routine screening of portal and splenic vein thrombosis after elective splenectomy is warranted because it allows to start anticoagulant therapy and avoid further life-threatening complications. The incidence of portal and splenic vein thrombosis is particularly high among patients operated on for lymphoma or with splenomegaly.[1][2][3]
References
- ↑ Bouvier A, Gout M, Audia S, Chalumeau C, Rat P, Deballon O (2017). "[Routine screening of splenic or portal vein thrombosis after splenectomy]". Rev Med Interne (in French). 38 (1): 3–7. doi:10.1016/j.revmed.2016.08.003. PMID 27639911.
- ↑ Valla D (2015). "Splanchnic Vein Thrombosis". Semin Thromb Hemost. 41 (5): 494–502. doi:10.1055/s-0035-1550439. PMID 26080307.
- ↑ Gouin B, Robert-Ebadi H, Casini A, Beauverd Y, Fontana P, Righini M; et al. (2017). "[Splanchnic vein thrombosis]". Rev Med Suisse. 13 (586): 2138–2143. PMID 29211374.